◀ Back to TNFSF11

CXCL13 — TNFSF11

Text-mined interactions from Literome

Yuvaraj et al., Mol Cancer Res 2009 (Carcinoma, Squamous Cell...) : Anti-CXCR5 chemokine receptor antibody abrogates CXCL13 induced RANKL expression in these cells ... CXCL13 treatment significantly increased ( 3.5-fold ) phospho-c-Jun levels in these cells and a c-Jun-NH ( 2 ) -kinase inhibitor abolished CXCL13 stimulated RANKL expression ... We also show that overexpression of NFATc3 stimulates RANKL expression/promoter activity and that siRNA suppression of NFATc3 abolished CXCL13 stimulated RANKL expression
Sambandam et al., Oncogene 2013 (Carcinoma, Squamous Cell...) : siRNA suppression of c-Myc expression markedly decreased CXCL13 induced RANKL and NFATc3 expression in preosteoblast cells